Jeffrey Sparks MD MMSc's Avatar

Jeffrey Sparks MD MMSc

@jeffsparks.bsky.social

Rheumatologist | Associate Professor of Medicine | @BrighamWomens | @harvardmed | Investigating rheumatoid arthritis susceptibility, RA-ILD, and outcomes | ⚡️⚡️

442 Followers  |  121 Following  |  25 Posts  |  Joined: 13.11.2024  |  2.1966

Latest posts by jeffsparks.bsky.social on Bluesky

Post image

🆕 Collaboration with RheumNow 🔵
3-Part Series on Interstitial Lung Disease

Part 2: Diagnosis & Subtypes of #ILD
👩🏻‍⚕️ What to look for on Physical Exam
🧪 Serologic Testing & Diagnostic Workup
🫁 Differentiating ILD Subtypes on Imaging

#RheumSky #PulmSky #MedSky #InterstitialLungDisease

17.09.2025 17:40 — 👍 6    🔁 1    💬 1    📌 0
Post image

I updated website for The COVID–19 Global Rheumatology Alliance so that the full GRA curriculum vitae is on the main page: rheum-covid.org

11.08.2025 01:07 — 👍 2    🔁 2    💬 1    📌 0

Happy to have compiled this review on the role of the intestinal mucosa in RA and SpA with my friends @kknoop.bsky.social‬, Joyce, Mario, and Kentaro.

We challenge the "leaky gut" hypothesis and why we shouldn't use that term that oversimplifies how our microbiome shapes immunity.

31.07.2025 15:26 — 👍 8    🔁 3    💬 0    📌 0

Alu expression in dermatomyositis muscle tissue
doi.org/10.1002/art....

Characterizing a cohort of patients with SpA spectrum disorders initially presenting as PMR
doi.org/10.1002/art....

Patients with RA-associated lung disease at increased risk of serious infection
doi.org/10.1002/art....

02.08.2025 13:01 — 👍 1    🔁 1    💬 1    📌 0

and NIAMS!

31.05.2025 10:42 — 👍 2    🔁 0    💬 0    📌 0
Preview
Fibroblasts in immune responses, inflammatory diseases and therapeutic implications Nature Reviews Rheumatology, Published online: 14 May 2025; doi:10.1038/s41584-025-01259-0This Review provides a comprehensive overview of fibroblast biology in rheumatoid arthritis and other chronic inflammatory diseases. The authors discuss insights into fibroblast behaviour and pathogenicity from single-cell and functional studies and describe how these findings have informed efforts to therapeutically target fibroblasts.

New content online:

14.05.2025 17:47 — 👍 7    🔁 4    💬 0    📌 0
Post image

ICYMI in our May issue—Survival in patients with rheumatoid #arthritis and recently diagnosed early-stage colorectal, lung, or prostate #cancer receiving TNF inhibitors bit.ly/3Q9Or8N

Plus, linked Comment by @jeffsparks.bsky.social & @nasingh.bsky.social bit.ly/42XQnsw
#Medsky #Rheumsky

14.05.2025 13:05 — 👍 2    🔁 1    💬 0    📌 0
EULAR/ACR risk stratification criteria (after simplification) for individuals with arthralgia at risk for rheumatoid arthritis, to be used in presence or absence of imaging

EULAR/ACR risk stratification criteria (after simplification) for individuals with arthralgia at risk for rheumatoid arthritis, to be used in presence or absence of imaging

Figure 2. Predicted risks (graph) and test characteristics and predictive values for several score cutoffs (table) for the risk stratification criteria with- out or with imaging. Predicted risks for the sum scores obtained in Table 4. Test characteristics and predictive values for several cutoffs of risk scores are shown; an extensive list of cutoffs with test characteristics and data on the percentage of persons with these cutoffs is presented in Supplemental Table S8. The area under the curve of the criteria without imaging is 0.80 and with MRI data is 0.85. MRI, magnetic resonance imaging; NPV, negative predictive value; PPV, positive predictive value; RA, rheumatoid arthritis; Sens, sensitivity; Spec, specificity

Figure 2. Predicted risks (graph) and test characteristics and predictive values for several score cutoffs (table) for the risk stratification criteria with- out or with imaging. Predicted risks for the sum scores obtained in Table 4. Test characteristics and predictive values for several cutoffs of risk scores are shown; an extensive list of cutoffs with test characteristics and data on the percentage of persons with these cutoffs is presented in Supplemental Table S8. The area under the curve of the criteria without imaging is 0.80 and with MRI data is 0.85. MRI, magnetic resonance imaging; NPV, negative predictive value; PPV, positive predictive value; RA, rheumatoid arthritis; Sens, sensitivity; Spec, specificity

EULAR/American College of Rheumatology Risk Stratification Criteria for Development of Rheumatoid Arthritis in the Risk Stage of Arthralgia

doi.org/10.1002/art....

Published simultaneously in Annals of Rheumatic Diseases

#Medsky #Rheumsky

08.05.2025 12:46 — 👍 6    🔁 2    💬 1    📌 0
Post image

⏰ It’s Today! 3:15, Charter 3

🗣️ BSR SARD-ILD Guidelines working group!

👋🏽 me - management
👋🏽 Muhammad Nisar - monitoring
👋🏽 Nazia Chaudari - screening

🪑 Clive Kelly @cliveryton

Come join us!! #ILD 🫁 🖐️!!
#BSR2025

30.04.2025 10:22 — 👍 3    🔁 1    💬 1    📌 0
Post image

Thank you to the #NephMadness Selection Committee members who helped us develop the teams in each region:

- @jordybc.bsky.social
- Mehmet Sever
- @thenestor.bsky.social
- @jeffsparks.bsky.social
- Mariana Murea
- @lawdishu.bsky.social
- Swee-Ling Levea
- Babak Orandi
- Susan Samuel

17.04.2025 15:23 — 👍 6    🔁 3    💬 1    📌 0
Preview
#NephMadness 2025 Champion: CAR-T for Autoimmune Diseases Here is is, fellow nephrons, as voted on by the Blue Ribbon Panel: your 2025 NephMadness champion! Check out the Final Standings and share your reactions with #NephMadness! Many thanks to Krithika …

#NephMadness 2025 Champion: CAR-T for Autoimmune Diseases

bit.ly/NM25Champ

@nephrosparks.bsky.social @annaburgner.bsky.social @kidneywars.bsky.social @jrkott27.bsky.social @catochita.bsky.social

08.04.2025 12:53 — 👍 10    🔁 7    💬 2    📌 1
Post image

The final results of #RheumMadness 2025 are out!

Read more about the panel's choices on our website, plus our list of thank you-s to all our collaborators who make this possible!
sites.duke.edu/rheummadness/

Thank you all for another great year!

07.04.2025 16:16 — 👍 7    🔁 2    💬 1    📌 1
Post image

Research Article

Serum Biomarkers of Pulmonary Damage and Risk for Progression of Rheumatoid Arthritis–Associated Interstitial Lung Disease

📖 www.jrheum.org/cgi/content/...
@jeffsparks.bsky.social

#biologicalmarkers #rheumatoidarthritis #interstitiallungdisease

02.04.2025 18:16 — 👍 1    🔁 1    💬 0    📌 0
Video thumbnail

Never played #RheumMadness ?

Think you don't have enough time to submit your bracket?

Think again. Submit with two simple steps:
1. Watch the 2-minute explainer video below
2. Head over to the tournament website and submit a bracket (IT'S FREE)

26.5 hours left!

tourneytopia.com/RheumMadness...

31.03.2025 01:29 — 👍 2    🔁 1    💬 0    📌 0
Preview
SGCAPS - RheumMadness Team: Ultrasound Avengers / Halo Heroes Base article: Sebastian A, van der Geest KSM, Tomelleri A, Macchioni P, Klinowski G, Salvarani C, Prieto-Peña D, Conticini E, Khurshid M, Dagna L, Brouwer E, Da...

Only 1.5 days left to submit your #RheumMadness bracket!

Next up on our countdown: SGCAPS + MSKUS prediction tool for #giantcellarteritis, by fellows from MCW.

Read it here:
sites.duke.edu/rheummadness...

30.03.2025 17:36 — 👍 2    🔁 1    💬 0    📌 0

Tolvaptan for hyponatremia was the first paper I ever summarized during journal club as a medical student! @nephrosparks.bsky.social

26.03.2025 01:34 — 👍 1    🔁 0    💬 0    📌 0

Incredible honor to participate in this year's #NephMadness- the tournament my brother @nephrosparks.bsky.social helped found years ago

My commentary about basketball (#Razorbacks), brotherhood, and RheumOnc / CAR-T

Also make sure to participate in #RheumMadness- CAR-T team there too

24.03.2025 20:52 — 👍 18    🔁 7    💬 0    📌 1
Post image

#NephMadness 2025: CAR-T for Autoimmunity – Driving to the Championship

Any my brother getting involved this year !!!! @jeffsparks.bsky.social

ajkdblog.org/2025/03/21/n...

23.03.2025 01:03 — 👍 13    🔁 6    💬 0    📌 1
Preview
#NephMadness 2025: CAR-T for Autoimmunity – Driving to the Championship Submit your picks! | @NephMadness | @nephmadness.bsky.social | NephMadness 2025   Jeffrey Sparks @jeffsparks – @jeffsparks.bsky.social Jeffrey A. Sparks is a rheumatologist and Associate Prof…

#NephMadness 2025: CAR-T for Autoimmunity – Driving to the Championship

Awesome to have the Sparks brothers in Nephmadness! @nephrosparks.bsky.social @jeffsparks.bsky.social

ajkdblog.org/2025/03/21/n...

22.03.2025 03:56 — 👍 6    🔁 5    💬 0    📌 0
Preview
#NephMadness 2025: CAR-T for Autoimmunity – Driving to the Championship Submit your picks! | @NephMadness | @nephmadness.bsky.social | NephMadness 2025   Jeffrey Sparks @jeffsparks – @jeffsparks.bsky.social Jeffrey A. Sparks is a rheumatologist and Associate Prof…

#NephMadness 2025 Commentary by @jeffsparks.bsky.social:

CAR-T for Autoimmunity – Driving to the Championship

bit.ly/NM25SparksCo...

21.03.2025 12:52 — 👍 2    🔁 3    💬 0    📌 0
Patients with systemic autoimmune rheumatic diseases remain at risk for hospitalisation for COVID-19 infection in the Omicron era (2022–2024): a retrospective cohort study Objective To investigate the risk factors for severe acute COVID-19 outcomes in the Omicron era among individuals with systemic autoimmune rheumatic diseases (SARDs). Methods We identified patients w...

Patients with systemic autoimmune rheumatic diseases remain at risk for hospitalisation for COVID-19 infection in the Omicron era (2022–2024): a retrospective cohort study rmdopen.bmj.com/content/11/1...

14.03.2025 01:21 — 👍 3    🔁 2    💬 0    📌 0

#RheumMadness + #NephMadness podcast is up!

CAR-T discussion starts at min 22:30

Find it here 👇
rheummadness.buzzsprout.com/1465681/epis...

@jeffsparks.bsky.social @nephmadness.bsky.social

12.03.2025 11:35 — 👍 4    🔁 3    💬 0    📌 0

one of those was on placebo though ?

12.03.2025 01:54 — 👍 2    🔁 0    💬 1    📌 0
Preview
#NephMadness 2025: The PodCrawl Submit your picks! |  @NephMadness |@nephmadness.bsky.social | NephMadness 2025 Over the next couple of weeks, NephMadness 2025 will be popping up on some great podcasts.  Keep your eyes and ears o…

#NephMadness 2025: The PodCrawl

buff.ly/p3xR3cg

Podcasts:
- @thecurbsiders.bsky.social
- Life as a Nephrology Professional @nkf-professionals.bsky.social
- GN in Ten
- @rheummadness.bsky.social
- @freelyfiltered.bsky.social
- Poison Lab
- Nephron Segment
- Kidney Chronicles

01.03.2025 14:12 — 👍 15    🔁 11    💬 0    📌 0
Preview
#NephMadness 2025: CAR-T for Kidney Disease Region Submit your picks! | @NephMadness | @nephmadness.bsky.social | NephMadness 2025 Selection Committee Member: Jeffrey Sparks @jeffsparks @jeffsparks.bsky.social Jeffrey A. Sparks is a rheumatologist …

#NephMadness 2025: CAR-T for Kidney Disease Region

buff.ly/iEgImMW

Teams:
- CAR-T for Autoimmune Disease
- CAR-T Side Effects

Expert: @jeffsparks.bsky.social
Writer: Yara Mouawad
Execs: Dia Waguespack & @annaburgner.bsky.social

01.03.2025 13:48 — 👍 5    🔁 4    💬 0    📌 0
Post image

#NephMadness 2025 is here!!! ajkdblog.org/2025/03/01/w...

01.03.2025 12:16 — 👍 18    🔁 14    💬 0    📌 1
Post image

Our March issue is live!

Including research on #ILD in #RheumatoidArthritis and #SystemicSclerosis, cardiovascular protection in #gout, and the burden of #arthritis in Australia, plus much more! www.thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky

25.02.2025 10:14 — 👍 10    🔁 7    💬 0    📌 0
Post image

At @science.org today, an important new way we can make major headway into immunologic and infectious diseases. Sequencing the lymphocyte B and T cell receptors and A.I. to accurately make the diagnosis!
www.science.org/doi/10.1126/science.adp2407
A seminal study by @anshulkundaje.bsky.social et al

20.02.2025 19:07 — 👍 295    🔁 64    💬 4    📌 2

NIH indirects case update:

Hearing ongoing now, and I'll try to live tweet some notable exchanges.

Prior to more detailed arguments, Judge Kelley starts off with a few point questions to both sides:

(I'm paraphrasing here)

21.02.2025 15:19 — 👍 349    🔁 198    💬 14    📌 38

@jeffsparks is following 20 prominent accounts